Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

1 Stock Under $65 That You Shouldn't Ignore

Leading biopharmaceutical company Gilead Sciences (GILD) reported impressive sales in the last quarter and raised its full-year 2022 guidance. Furthermore, the company’s strategic acquisitions, drug approvals, and research breakthroughs should drive its growth in the coming quarters. Given GILD’s discounted valuation, we think it could be wise to buy this…

StockNews.com

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ social media trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

The Independent UK

4.4M Americans roll up sleeves for omicron-targeted boosters

More than 4 million Americans have rolled up their sleeves for the new omicron-specific booster shots

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

U.S. cutting global donations of Pfizer COVID shots as demand slows

The United States is significantly cutting back the number of Pfizer/BioNTech COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries.

Reuters

Pfizer, US revise contract for donated vaccines as world demand plummets

WASHINGTON — President Joe Biden’s administration has slashed its target for COVID-19 vaccine donations abroad this year, amending a contract with Pfizer Inc. in the latest sign that world demand for the shots has collapsed.

Tribune News Service

Lawmakers strike deal on FDA user fee bill

WASHINGTON — Senate committee leaders have struck an agreement to reauthorize five-year user fee deals for the Food and Drug Administration, although details of a broader stopgap government spending bill remain unfinished.

Tribune News Service

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Men ran Breaking Bad style drugs lab worth up to £10m a month

Keith Davis and Andrew Gurney have had their 'lenient' jail sentences extended

Liverpool Echo

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.

Benzinga

France to make morning after pill free for all women and girls

Free screening for sexually transmitted infections for all young people is also being extended

The Independent UK

Two men who ran £11m Breaking Bad-style meth amphetamine lab have ‘lenient’ sentences increased

Operation produced up amphetamine sulphate and was one of the largest factories ever found in the UK

The Independent UK

Experts raise concern over ‘diet pills’ promoted on social media

TikTok branded ‘worst culprit’ for bombarding users with misinformation

The Independent UK

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ TikTok trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

The Independent UK

Hamilton Accies Community Trust in cash boost from global pharmaceutical firm

AstraZeneca is supporting the work the Trust does across the Lanarkshire community.

Daily Record

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Lepu ScienTech Revives IPO After Policy Move Brightens Its Prospects

Key Takeaways: After taking its Lepu Biopharma unit public in February, Lepu Medical is pressing ahead with a third attempt at listing is Lepu ScienTech unit in Hong Kong

Benzinga

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

WEKU

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Birmingham Post

Leading Welsh life sciences company Diurnal in £48m takeover by US firm

The board of Diurnal have recommended the takeover bid from Neurocrine

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

Biden declared victory over big pharma – but is it enough to sway senior voters?

The Inflation Reduction Act aims to reduce the cost of drugs, but the law’s limitations may not help the Democrats in the midterms

The Independent UK

Don’t cook your chicken in Nyquil, FDA warns after viral social media trend resurfaces

“These video challenges, which often target youths, can harm people — and even cause death,” the agency said.

Tribune News Service

Shortages of Moderna COVID-19 boosters seen in US

Some of the nation's pharmacies are reporting shortages of Moderna Inc.’s new bivalent booster shot for COVID-19 as one factory used in producing the vaccine remains offline following a safety inspection.

The Independent UK

FDA concedes delays in response to baby formula shortage

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

The Guardian - UK

The only party not getting heartburn over GSK demerger is the lawyers

The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

Reuters

EU health regulator says COVID pandemic not over

An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not over, contradicting U.S. President Joe Biden, and that a planned vaccination campaign in the region during the cold season was key to fighting it.

1 … 126 127 128 129

People

Joe Biden

67,642 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.